Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$257M |
| 2 |
Toronto Dominion Bank
TD
|
+$192M |
| 3 |
Enbridge
ENB
|
+$167M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$129M |
| 5 |
Bank of America
BAC
|
+$128M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTRX
CATAMARAN CORP COM STK (CDA)
CTRX
|
+$169M |
| 2 |
Thomson Reuters
TRI
|
+$150M |
| 3 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$132M |
| 4 |
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
|
+$110M |
| 5 |
Deutsche Bank
DB
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.9% |
| 2 | Energy | 10.67% |
| 3 | Industrials | 8.6% |
| 4 | Communication Services | 7.36% |
| 5 | Healthcare | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGU
4126
PUT
DELISTED
Agrium
AGU
| $224K | ﹤0.01% |
2,500
-26,000
| -91% | -$2.63M |
|
4127
Cousins Properties
CUZ
$4.89B
| $223K | ﹤0.01% |
8,540
+5,158
| +153% | +$142K |
|
4128
WisdomTree US LargeCap Fund
EPS
$1.66B
| $223K | ﹤0.01% |
10,197
-6,531
| -39% | -$152K |
|
4129
McEwen Inc
MUX
$1.15B
| $223K | ﹤0.01% |
25,439
+15,299
| +151% | +$127K |
|
4130
Foster
FSTR
$408M
| $222K | ﹤0.01% |
18,056
+14,910
| +474% | +$332K |
|
|
MRCC
4131
DELISTED
Monroe Capital Corp
MRCC
| $222K | ﹤0.01% |
15,956
+31
| +0.2% | +$457 |
|
4132
Turkcell
TKC
$4.75B
| $222K | ﹤0.01% |
25,574
-1,114
| -4% | -$11.5K |
|
|
SIOX
4133
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $222K | ﹤0.01% |
2,148
+2,085
| +3,310% | +$244K |
|
|
NPP
4134
DELISTED
NUVEEN PERFORMANCE+MUN FUND
NPP
| $222K | ﹤0.01% |
15,643
+5,493
| +54% | +$77.3K |
|
|
PXMC
4135
DELISTED
POWERSHARES FUNDAMENTAL PURE MID CORE PORTFOLIO
PXMC
| $222K | ﹤0.01% |
6,274
+2,410
| +62% | +$85.3K |
|
|
CHN
4136
DELISTED
China Fund
CHN
| $221K | ﹤0.01% |
13,854
-20,350
| -59% | -$349K |
|
|
DVAX
4137
DELISTED
Dynavax Technologies
DVAX
| $221K | ﹤0.01% |
8,991
+8,521
| +1,813% | +$241K |
|
4138
Sarepta Therapeutics
SRPT
$1.91B
| $221K | ﹤0.01% |
6,877
+2,587
| +60% | +$87.8K |
|
|
PGNX
4139
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $221K | ﹤0.01% |
38,687
+38,652
| +110,434% | +$297K |
|
|
CCRN
4140
DELISTED
Cross Country Healthcare
CCRN
| $220K | ﹤0.01% |
16,186
+4,356
| +37% | +$59.2K |
|
4141
Invesco MSCI Sustainable Future ETF
ERTH
$138M
| $220K | ﹤0.01% |
8,352
+1,850
| +28% | +$53.3K |
|
4142
Global X SuperDividend US ETF
DIV
$786M
| $219K | ﹤0.01% |
9,139
-1,494
| -14% | -$37.9K |
|
|
EFR
4143
Eaton Vance Senior Floating-Rate Fund
EFR
$317M
| $218K | ﹤0.01% |
16,546
+3,150
| +24% | +$43K |
|
|
HEP
4144
DELISTED
Holly Energy Partners, L.P.
HEP
| $218K | ﹤0.01% |
7,503
-2,661
| -26% | -$83K |
|
|
MLNX
4145
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $218K | ﹤0.01% |
5,755
-39,778
| -87% | -$1.71M |
|
|
ARRY
4146
DELISTED
Array Biopharma Inc
ARRY
| $218K | ﹤0.01% |
47,875
+37,554
| +364% | +$223K |
|
|
BLT
4147
DELISTED
BLOUNT INTERNATIONAL (NEW)
BLT
| $218K | ﹤0.01% |
39,255
+18,406
| +88% | +$136K |
|
|
DGI
4148
DELISTED
DigitalGlobe Inc.
DGI
| $218K | ﹤0.01% |
11,480
+9,254
| +416% | +$219K |
|
|
POM
4149
PUT
DELISTED
PEPCO HOLDINGS, INC.
POM
| $218K | ﹤0.01% |
+9,000
| New | +$229K |
|
4150
Healthcare Realty
HR
$6.6B
| $217K | ﹤0.01% |
8,856
-961
| -10% | -$23.7K |
|
Similar funds
Royal Bank of Canada's Q3 2015 Portfolio in Review
As of Q3 2015, Royal Bank of Canada held 7,125 positions worth $134B, down 7.7% from $145B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Royal Bank of Canada's Q3 2015 filing shows 455 new, 2,592 increased, 3,012 reduced and 325 closed positions. Its largest new stake was Kraft Heinz: 1,455,759 shares worth $103M. The largest sale was CATAMARAN CORP COM STK (CDA), an estimated $169M.
By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 26% a quarter earlier, followed by Energy and Industrials.
- Royal Bank of Canada's largest Q3 2015 buy was Kraft Heinz: 1,455,759 shares worth $103M.
- Royal Bank of Canada added most to Apple in Q3 2015, an estimated $257M increase.
- Royal Bank of Canada's biggest Q3 2015 reduction was Thomson Reuters, cutting an estimated $150M.
- Royal Bank of Canada fully exited CATAMARAN CORP COM STK (CDA) in Q3 2015, selling an estimated $169M.
- Royal Bank of Canada's ten largest holdings make up 25% of its $134B portfolio in Q3 2015.
- Royal Bank of Canada opened 455 new positions and closed 325 in Q3 2015.
- Royal Bank of Canada's portfolio value fell 7.7% quarter-over-quarter to $134B.
Based on Royal Bank of Canada's 13F filing for Q3 2015, filed 16 Nov 2015.